← All companies

CUBT

Curative Biotechnology, Inc.

CUBT OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.48

+0.19 +14.51%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.03 – $1.99

Recent SEC filings

40 most recent

Other filings

RW Dec 22, 2025 S-1/A Aug 1, 2025 S-1 May 6, 2024 RW Feb 1, 2024 S-1/A Jan 25, 2023 D Item 06b Jan 18, 2023 S-1/A Jan 13, 2023 S-1/A Jan 9, 2023 8-A12B/A Dec 1, 2022 S-1/A Nov 30, 2022 S-1/A Nov 16, 2022 S-1 Nov 7, 2022 RW Oct 31, 2022 EFFECT Item S-1; Item 2022-10-13; Item 09:00:00 Oct 13, 2022 CORRESP Oct 11, 2022 CERT NYSE AMERICAN CERTIFICATION Oct 5, 2022 8-A12B Oct 5, 2022 CORRESP Sep 30, 2022 S-1/A Sep 30, 2022 UPLOAD Sep 29, 2022 S-1/A Sep 28, 2022 CORRESP Sep 9, 2022 S-1/A Sep 9, 2022 UPLOAD Sep 8, 2022 S-1/A Sep 1, 2022 CORRESP Aug 10, 2022 S-1/A Aug 10, 2022 UPLOAD Aug 8, 2022 S-1/A Aug 1, 2022 S-1/A Jul 8, 2022 CORRESP Jul 8, 2022 UPLOAD Jul 7, 2022 S-1/A Jun 29, 2022 CORRESP Apr 25, 2022 S-1/A Apr 25, 2022 UPLOAD Apr 21, 2022 CORRESP Apr 15, 2022 S-1 Apr 15, 2022 UPLOAD Apr 5, 2022 DRSLTR Mar 28, 2022